NCT01968590: A trial that was reported late by University of Utah
This trial has reported, although it was 198 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01968590 |
|---|---|
| Title | A Phase II Trial on the Effect of Low-Dose Versus High-Dose Vitamin D Supplementation on Bone Mass in Adults With Neurofibromatosis Type 1 (NF1) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 16, 2017 |
| Completion date | Jan. 1, 2022 |
| Required reporting date | Jan. 1, 2023, midnight |
| Actual reporting date | July 18, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 198 |